Genomic Profiling for Clinical Decision Making in Hematologic Malignancies

February 6, 2025

- This dinner program will be a virtual (online) event. -

Overview

Precision medicine has revolutionized cancer care in recent years. Novel therapies are now approved on the basis of the presence of specific molecular alterations and consensus guidelines are increasingly incorporating molecular testing to contribute to diagnosis refinement, risk stratification, and therapy selection. Next-generation sequencing (NGS) has become an essential part of personalized cancer care. This program will focus on the use of NGS for both myeloid and lymphoid neoplasms, highlighting how to identify clinically significant molecular alterations and incorporate these findings into patient care.

Learning Objectives.

  1. Identify clinically significant molecular alterations on next-generation sequencing (NGS) reports
  2. Describe strategies for incorporating NGS results into treatment planning for patients with hematologic malignancies
  3. Review how genomic biomarkers can inform pharmacotherapy selection in various hematologic malignancies

Target Audience

This activity is intended for oncology nurse practitioners, physician assistants, nurses, nurse navigators, medical assistants, and other healthcare providers involved in the care of cancer patients.

Presented By

                               

Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
    Horizon CME designates this Live activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 1.00 ANCC
    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the American Nurses Credentialing Center’s Commission on Accreditation through the joint providership of the Nurse Practitioner Healthcare Foundation and Horizon CME. The Nurse Practitioner Healthcare Foundation is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. NPHF is awarding the contact hours and is responsible for adherence to the ANCC criteria. Upon completion, NPs and RNs will be awarded up to 1.00 credit.
  • 0.50 Pharmacology
    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the American Nurses Credentialing Center’s Commission on Accreditation through the joint providership of the Nurse Practitioner Healthcare Foundation and Horizon CME. The Nurse Practitioner Healthcare Foundation is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. NPHF is awarding the contact hours and is responsible for adherence to the ANCC criteria. Upon completion, NPs and RNs will be awarded up to 0.50 credit.
Course opens: 
11/13/2024
Course expires: 
03/07/2025
Event starts: 
02/06/2025 - 8:55pm PST
Event ends: 
02/06/2025 - 10:30pm PST
Cost:
$0.00
Add to calendar: 
Rating: 
0

Agenda

All Times Listed are for the Hawaii Standard Time Zone

Thursday, February 6, 2025

5:55pmWelcome and Introduction
» Rachel Thelen, MSN, FNP-C, AOCNP - Oncology Nurse Practitioner Maui Memorial Medical Center
6:00pmMeet-the-Clinicians Exhibits (non-CME) 
6:30pmGenomic Profiling for Clinical Decision Making in Hematologic Malignancies
» Todd Knepper, PharmD - Associate Member, Precision Medicine Department of Pathology Moffitt Cancer Center
7:30pmClosing Comments
» Rachel Thelen, MSN, FNP-C, AOCNP - Oncology Nurse Practitioner Maui Memorial Medical Center
7:35pmExhibits (non-CME)
Online - Virtual Event
United States

Faculty

 

Rachel Thelen, MSN, FNP-C, AOCNP (Moderator)

Rachel Thelen is an Oncology Certified Nurse Practitioner at the Maui Memorial Medical Center Outpatient Clinic. She received her Bachelor of Science in Nursing from UNC Wilmington in 2009 and Master of Science in Nursing from Western Carolina University in 2016. She has over fourteen years of hematology/oncology experience. She began her career as an inpatient oncology nurse, followed by outpatient infusion and now, as an advanced oncology practitioner since 2016. She relocated from the east coast to Maui in 2020 with her husband, John, and daughter, Ruby.

 

Todd Knepper, PharmD

Dr. Todd Knepper is an Associate Member in the Precision Medicine Program of the Department of Pathology at Moffitt Cancer Center. He graduated with his PharmD degree from the University of North Carolina - Eshelman School of Pharmacy, completed a Personalized Cancer Medicine Fellowship at Moffitt Cancer Center, and gained regulatory experience as an ORISE fellow at the US FDA with the Genomics and Targeted Therapy group. At Moffitt, he was a key part of the creation and development of Moffitt’s Precision Medicine Program, bringing cancer genomics into the clinic through the molecular tumor board and Precision Medicine Clinical Service.

As an Attending on the clinical service, he provides clinically meaningful interpretations of tumor next-generation sequencing results for patients with solid tumors and hematologic malignancies and is Precision Medicine Clinical Service rotation leader for 2nd -year heme-onc fellows. His research focuses on the utilization of genomics to improve therapeutic strategies for the treatment of patients with cancer and to advance understanding of cancer biology. He has co-authored over thirty scientific manuscripts, including in high-impact journals such as the Journal of Clinical Oncology, Blood, Clinical Cancer Research, the Lancet, and Nature.

Disclosures:

Horizon CME requires all planners, faculty, and other contributors to disclose any financial relationships with an ACCME defined ineligible company within the past 24 months and Horizon CME has resolved any conflicts prior to this educational activity.

 

All other non-faculty contributors and others involved in the planning, development and editing/review of the content disclosed no relevant financial relationships with any entity producing, marketing, re-selling or distributing health care goods or services consumed by or used on patients.

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
    Horizon CME designates this Live activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 1.00 ANCC
    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the American Nurses Credentialing Center’s Commission on Accreditation through the joint providership of the Nurse Practitioner Healthcare Foundation and Horizon CME. The Nurse Practitioner Healthcare Foundation is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. NPHF is awarding the contact hours and is responsible for adherence to the ANCC criteria. Upon completion, NPs and RNs will be awarded up to 1.00 credit.
  • 0.50 Pharmacology
    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the American Nurses Credentialing Center’s Commission on Accreditation through the joint providership of the Nurse Practitioner Healthcare Foundation and Horizon CME. The Nurse Practitioner Healthcare Foundation is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. NPHF is awarding the contact hours and is responsible for adherence to the ANCC criteria. Upon completion, NPs and RNs will be awarded up to 0.50 credit.

Price

Cost:
$0.00
Please login or register to take this course.

Required Hardware/software

Access to the internet is required.

Supported Browsers:

Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above

Google Chrome 28.0+ for Windows, Mac OS, or Linux

Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux

Safari 6.0+ for Mac OSX 10.7 and above


Supported Phones & Tablets:

Android 4.0.3 and above

iPhone/iPad with iOS 6.1 or above